Songlin Xue, M.D., Ph.D., is Executive Vice President and Head of the global Pharmacovigilance in Astellas. In this position, he leads a global pharmacovigilance organization that includes pharmacovigilance operation and processes, medical safety, risk management, and epidemiology functions as well as pharmacovigilance functions in all affiliate countries. This global pharmacovigilance organization has the primary responsibilities for safety and pharmacovigilance compliance of all clinical development compounds and post-approval products worldwide.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)